/A

Conditions: Coronary artery by-pass surgery patients
MedDRA version: 14.1Level: LLTClassification code 10011076Term: Coronary artery atherosclerosisSystem Organ Class: 10007541 - Cardiac disorders
Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

Registration Number: EUCTR2012-000458-72-FI

Lead Sponsor: Juha Hartikainen

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Authorised-recruitment may be ongoing or finished

Sex: All

Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

Not provided

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Patients;Secondary Objective: None;Primary end point(s): concentration of metoprolol in plasma after dosage of the drug, difference between study and placebo group;Timepoint(s) of evaluation of this end point: metoprolol level in plasma 4, 6, 8, and 12 hours after administration, same protocol 4 days postoperatively

Secondary Outcome Measures